Clinical Trial Update: Study of AZD0754 in Participants With Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

AstraZeneca's AZD0754 is being studied in a Phase 1/2 trial for metastatic prostate cancer, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• AZD0754

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING